N
Nanjing Best Bioengineering
At a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- China
- Open positions
- None listed
- Dealroom signal
- 14.3/100
- Industry
- Energy
- Sector
- Energy, Biotechnology, Hard Tech
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2023 | $34M | $138M | Hillhouse Capital · Daoxing Investment · Hainan Xuanwan · Nanjing Lixu | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Nanjing Best Bioengineering in its local ecosystem
The Nanjing Best Bioengineering office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Hillhouse Capital- DIDaoxing Investment
- HXHainan Xuanwan
- NLNanjing Lixu
- HHHainan Haiying
Huatai Zijin Investment- ZIZhibai Investment
- NHNanjing Huahai
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nanjing Best Bioengineering on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nanjing Best Bioengineering’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









